is glp 1 safe with kidney disease Frontiers Glucagon-like peptide-1 receptor agonists in
Description
Another 2025 survey published in JAMA Health Forum noted that, should Medicare pay for the drugs, it could avoid spending a hypothetical $18.2 billion on obesity-related health expenditures over 10 years while dishing out $65.9 billion annually on the GLP-1s by year 10, thereby negating any savings

Novo Nordisk, Copenaghen, Denmark

Planned pregnancy GLP-1 medications are not recommended during pregnancy, and most guidelines suggest stopping before attempting to conceive

Comparison with patients switching from semaglutide to another GLP-1 RA would also be valuable

Why are they so much cheaper than prescriptions
doi: 10.1097/00041327-199403000-00011
